Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects

ClinicalTrials.gov ID: NCT03687632

Public ClinicalTrials.gov record NCT03687632. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Open Label Trial of ST266 Eye Drops in the Treatment of Persistent Corneal Epithelial Defects

Study identification

NCT ID
NCT03687632
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Noveome Biotherapeutics, formerly Stemnion
Industry
Enrollment
13 participants

Conditions and interventions

Interventions

  • ST266 Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 9, 2019
Primary completion
Aug 17, 2020
Completion
Aug 24, 2020
Last update posted
Aug 17, 2021

2019 – 2020

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Price Vision Group Indianapolis Indiana 46260
Cincinnati Eye Institute Edgewood Kentucky 41017
University of Maryland Baltimore Maryland 21201
Tufts Medical Center Boston Massachusetts 02111
Cleveland Clinic Cleveland Ohio 44195
University of Pennsylvania Philadelphia Pennsylvania 19104
Univesity of Pittsburgh Pittsburgh Pennsylvania 15213
University of West Virginia Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03687632, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03687632 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →